MedTrace Logo

Munich ME/CFS Cohort Study

NCT06005246 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-08-22

No results posted yet for this study

Summary

The Munich cohort study MUC-CFS aims at the characterization and long-term follow-up of myalgic encephalitis/chronic fatigue syndrome (ME/CFS) in young people aged up to 25 years, as well as at the identification of pathomechanisms, biomarkers, and targets for future treatment approaches.

Conditions

  • Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (ICD-10 G93.3)

Sponsors & Collaborators

  • Helmholtz Munich, Munich

    collaborator UNKNOWN

  • German Cancer Research Center

    collaborator OTHER

  • Charité University Hospital, Berlin, Germany

    collaborator UNKNOWN

  • Technical University of Munich

    lead OTHER

Principal Investigators

  • Uta Behrends, Prof. Dr. · München Klinik Schwabing

Eligibility

Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-22
Primary Completion
2024-01-31
Completion
2029-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06005246 on ClinicalTrials.gov